5T4 (trophoblast glycoprotein, TPBG) is an oncofetal antigen—a cell-surface glycoprotein that is highly expressed on many carcinomas (e.g., renal, lung, colorectal, ovarian) but has limited expression in normal adult tissues. Its overexpression is associated with poor prognosis, metastasis, and epithelial-mesenchymal transition (EMT).